Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | STK39 | Q9UEW8 | 1/20 | 0.40 |
| ▸ | TACR1 | P25103 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 3/20 | 0.39 |
| ▸ | TDO2 | P48775 | 3/20 | 0.39 |
| ▸ | ACLY | P53396 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28332952 | 0.94 | SRC (0.48) | SRCL3MBTL1STK39TACR1PPARA | |
| SCHEMBL28436668 | 0.87 | MEN1 (0.40) | L3MBTL1KMT2AMEN1 | |
| SCHEMBL21061039 | 0.84 | CA1 (0.36) | ALDH1A1KMT2A | |
| SCHEMBL28328822 | 0.83 | CES2 (0.43) | PPARAIDO1TDO2KMT2APPARG | |
| SCHEMBL19892726 | 0.83 | L3MBTL1 (0.40) | L3MBTL1KMT2AMEN1MAPTCNR2 | |
| SCHEMBL20897901 | 0.81 | RAB9A (0.44) | L3MBTL1ALDH1A1KMT2APPARGMEN1 | |
| SCHEMBL11219221 | 0.81 | SRC (0.47) | SRCL3MBTL1ALDH1A1KMT2AMMP8 | |
| SCHEMBL12477325 | 0.80 | CES2 (0.47) | STK39ALDH1A1IDO1TDO2KMT2A | |
| SCHEMBL1273928 | 0.78 | CES2 (0.40) | ALDH1A1ACLYKMT2APPARGMEN1 | |
| SCHEMBL15671624 | 0.78 | P2RX1 (0.40) | ACLY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159562-A1 | PYRIMIDINIUM COMPOUNDS AND THEIR MIXTURES FOR COMBATING ANIMAL PESTS | BASF SE (DE) | 2023-05-25 | — | — | US | disclosed |
| CN-116102580-A | Pyrimidinium compounds and mixtures thereof for combating animal pests | 巴斯夫欧洲公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-116076518-A | Pyrimidinium compounds and mixtures thereof for combating animal pests | 巴斯夫欧洲公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-116082366-A | Pyrimidinium compounds and mixtures thereof for combating animal pests | 巴斯夫欧洲公司 | 2023-05-09 | — | — | CN | disclosed |
| US-11578083-B2 | Pyrimidinium compounds and their mixtures for combating animal pests | BASF SE (DE) | 2023-02-14 | — | — | US | disclosed |
| CN-110621677-B | Process for preparing chiral 2, 3-dihydrothiazolo [3,2-A ] pyrimidin-4-ium compounds | 巴斯夫欧洲公司 | 2022-06-07 | — | — | CN | disclosed |
| EP-2984089-B1 | SUBSTITUTED PYRIMIDINIUM COMPOUNDS AND DERIVATIVES FOR COMBATING ANIMAL PESTS | BASF SE (DE) | 2022-03-09 | — | — | EP | disclosed |
| EP-3601298-B1 | PROCESS FOR PREPARING CHIRAL 2,3-DIHYDROTHIAZOLO[3,2-A]PYRIMIDIN-4-IUM COMPOUNDS | BASF SE (DE) | 2021-12-01 | — | — | EP | disclosed |
| US-20210355139-A1 | Pyrimidinium Compounds and Their Mixtures for Combating Animal Pests | BASF SE (DE) | 2021-11-18 | — | — | US | disclosed |
| CN-111153900-B | Pyrimidinium compounds, process for their preparation and their use | 东莞市东阳光农药研发有限公司 | 2021-09-28 | — | — | CN | disclosed |
| WO-2011017342-A2 | MESOIONIC PESTICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-02-10 | — | — | WO | disclosed |
| US-20100323887-A1 | MESOIONIC PESTICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-12-23 | — | — | US | disclosed |
| EP-2240454-A1 | MESOIONIC PESTICIDES | E. I. du Pont de Nemours and Company (US) | 2010-10-20 | — | — | EP | disclosed |
| WO-2009099929-A1 | MESOIONIC PESTICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-08-13 | — | — | WO | disclosed |
| US-20090048276-A1 | Inhibitors of Fatty Acid Synthase (Fas) | MERCK SHARP & DOHME CORP. | 2009-02-19 | — | — | US | disclosed |
| US-20090048276-A1 | Inhibitors of Fatty Acid Synthase (Fas) | MERCK SHARP & DOHME CORP. | 2009-02-19 | — | — | US | disclosed |
| US-20090048276-A1 | Inhibitors of Fatty Acid Synthase (Fas) | MERCK SHARP & DOHME CORP. | 2009-02-19 | — | — | US | disclosed |
| EP-1981341-A2 | INHIBITORS OF FATTY ACID SYNTHASE (FAS) | Merck and Co., Inc. (US) | 2008-10-22 | — | — | EP | disclosed |
| WO-2007089634-A2 | INHIBITORS OF FATTY ACID SYNTHASE (FAS) | MERCK & CO., INC. (US) | 2007-08-09 | — | — | WO | disclosed |
| WO-2007089634-A2 | INHIBITORS OF FATTY ACID SYNTHASE (FAS) | MERCK & CO., INC. (US) | 2007-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159562-A1 | PYRIMIDINIUM COMPOUNDS AND THEIR MIXTURES FOR COMBATING ANIMAL PESTS | THOP1, NIT2, DDT | SRC 3904/4885L3MBTL1 1196/4885STK39 1073/4885 |
| US-11578083-B2 | Pyrimidinium compounds and their mixtures for combating animal pests | THOP1, NIT2, DDT | SRC 3801/4885L3MBTL1 1311/4885STK39 1072/4885 |
| US-20100323887-A1 | MESOIONIC PESTICIDES | DDT, CHRM1, CHRM3 | SRC 781/4885L3MBTL1 417/4885STK39 1855/4885 |
| US-20090048276-A1 | Inhibitors of Fatty Acid Synthase (Fas) | FASN, FADS2, FADS1 | SRC 2529/4885L3MBTL1 2846/4885STK39 3640/4885 |
| US-20210355139-A1 | Pyrimidinium Compounds and Their Mixtures for Combating Animal Pests | THOP1, NIT2, DDT | SRC 3801/4885L3MBTL1 1311/4885STK39 1072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.